Cite

HARVARD Citation

    Wu, Z. et al. (2021). Safety and immunogenicity of a novel oral hexavalent rotavirus vaccine:a phase I clinical trial. Human vaccines & immunotherapeutics. 17 (7), pp. 2311-2318. [Online]. 
  
Back to record